BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36854819)

  • 1. Effect of Roux-En-Y Gastric Bypass in the Pharmacokinetics of (R)-Carvedilol and (S)-Carvedilol.
    Yamamoto PA; Cristofoletti R; Vozmediano V; de Gaitani CM; da Silva RM; Kemp R; Sankarankutty AK; Salgado Junior W; Santos JSD; de Moraes NV
    J Clin Pharmacol; 2023 Jul; 63(7):838-847. PubMed ID: 36854819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls.
    Ginstman C; Kopp Kallner H; Fagerberg-Silwer J; Carlsson B; Ärlemalm A; Böttiger Y; Brynhildsen J
    Obes Surg; 2020 Jun; 30(6):2217-2224. PubMed ID: 32030619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sleeve gastrectomy and Roux-en-Y gastric bypass on gastrointestinal physiology.
    Steenackers N; Vanuytsel T; Augustijns P; Deleus E; Deckers W; Deroose CM; Falony G; Lannoo M; Mertens A; Mols R; Vangoitsenhoven R; Wauters L; Van der Schueren B; Matthys C
    Eur J Pharm Biopharm; 2023 Feb; 183():92-101. PubMed ID: 36603693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.
    Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypass.
    Maghsoodi N; Alaghband-Zadeh J; Cross GF; Werling M; Fändriks L; Docherty NG; Olbers T; Dew T; Sherwood RA; Vincent RP; le Roux CW
    Ann Clin Biochem; 2017 Jul; 54(4):495-500. PubMed ID: 27555664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of weight loss after gastric bypass, sleeve gastrectomy, and adjustable gastric banding.
    Azagury D; Mokhtari TE; Garcia L; Rosas US; Garg T; Rivas H; Morton J
    Surgery; 2019 Mar; 165(3):565-570. PubMed ID: 30316577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Banded Roux-en-Y gastric bypass in patients with super morbid obesity (BRandY-study): protocol of a cohort study with 10 year follow-up.
    Romeijn MM; Leclercq WKG; Luijten AAPM; Janssen L; van Dielen FMH
    BMC Surg; 2020 Jun; 20(1):122. PubMed ID: 32503510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative changes in prouroguanylin hormone response in severely obese subjects after bariatric surgery.
    Torquati A; Shantavasinkul PC; Omotosho P; Corsino L; Spagnoli A
    Surgery; 2019 Oct; 166(4):456-459. PubMed ID: 31472974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.
    Han Y; Jia Y; Wang H; Cao L; Zhao Y
    Int J Surg; 2020 Apr; 76():101-110. PubMed ID: 32151750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures.
    Tice JA; Karliner L; Walsh J; Petersen AJ; Feldman MD
    Am J Med; 2008 Oct; 121(10):885-93. PubMed ID: 18823860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.
    Mitrov-Winkelmolen L; van Buul-Gast MW; Swank DJ; Overdiek HWPM; van Schaik RHN; Touw DJ
    Obes Surg; 2016 Sep; 26(9):2051-2058. PubMed ID: 26797705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plastic surgery improves long-term weight control after bariatric surgery.
    Balagué N; Combescure C; Huber O; Pittet-Cuénod B; Modarressi A
    Plast Reconstr Surg; 2013 Oct; 132(4):826-833. PubMed ID: 24076675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Sustained is Roux-en-Y Gastric Bypass Long-term Efficacy? : Roux-en-Y Gastric Bypass efficacy.
    Guimarães M; Osório C; Silva D; Almeida RF; Reis A; Cardoso S; Pereira SS; Monteiro MP; Nora M
    Obes Surg; 2021 Aug; 31(8):3623-3629. PubMed ID: 34021884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H. PYLORI INFECTION, ENDOSCOPIC, HISTOLOGICAL ASPECTS AND CELL PROLIFERATION IN THE GASTRIC MUCOSA OF PATIENTS SUBMITTED TO ROUX-EN-Y GASTRIC BYPASS WITH CONTENTION RING: a cross sectional endoscopic and immunohistochemical study.
    Nogueira Tde B; Artigiani R; Herani B; Waisberg J
    Arq Gastroenterol; 2016; 53(1):55-60. PubMed ID: 27281506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial.
    Kraljević M; Delko T; Köstler T; Osto E; Lutz T; Thommen S; Droeser RA; Rothwell L; Oertli D; Zingg U
    Trials; 2017 May; 18(1):226. PubMed ID: 28532499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics.
    Rossi I; Omotosho P; Poirier J; Spagnoli A; Torquati A
    Surgery; 2021 Mar; 169(3):539-542. PubMed ID: 33168209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Mini vs Roux-en-Y gastric bypass: A meta-analysis and systematic review.
    Wang FG; Yan WM; Yan M; Song MM
    Int J Surg; 2018 Aug; 56():7-14. PubMed ID: 29753952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population-based analysis.
    Yamamoto PA; Vozmediano V; Cristofoletti R; Jiang J; Schmittgen TD; de Gaitani CM; Kemp R; Sankarankutty AK; Dos Santos JS; Salgado Junior W; de Moraes NV
    Br J Clin Pharmacol; 2024 Jun; ():. PubMed ID: 38852609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revision Roux-en-Y Gastric Bypass to Biliopancreatic Long-Limb Gastric Bypass for Inadequate Weight Response: Case Series and Analysis.
    Buchwald H; Oien DM
    Obes Surg; 2017 Sep; 27(9):2293-2302. PubMed ID: 28405877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.